in which malignant cells express diverse phenotypes and cer encountered in children. Little is known about the molecurespond variably to chemotherapy. Alteration of genes in a lar pathology of childhood T cell ALL. Oncogenesis is a multicell-type-specific manner could be associated with the disstep process that involves alterations in proto-oncogenes and crepancies in the observed phenotypes. In this regard, the ted with the development of the disease. We examined 56
ALL, 14 but not in pre-B cell type. Few other specific genetic human carcinogenesis is caused by defects in the DNA alterations have been found in a significant number of T cell replication/repair system. To study the involvement of some of ALL patients investigated. Such a heterogeneity could be these mutational events in the development of T cell ALL, we partly explained by the observation that mismatch repairhave initiated a systematic search for losses of heterozygosity deficient cell lines survive from exposure to alkylating agents (LOH) and microsatellite instabilities in children affected with used in cancer chemotherapy. 15, 16 Since treatment failure in this disease. These patients were allelotyped by PCR using 56 microsatellite markers located near known or putative tumor ALL is frequently associated with the development of drugsuppressor genes. The microsatellite patterns were altered in resistant clones, 17 genomic instability could be involved in more than 80% of the patients. LOH were detected in chromo-ALL patients refractory to chemotherapy. On the other hand, somes 6p, 12p and 9p. Two third of the patients were deleted it has been reported that certain tumors associated with a mut- with T cell ALL, in order to identify the genetic events associa-
ted with the development of the disease. We examined 56
Keywords: mutator phenotype; microsatellite instability; mismatch microsatellite loci covering 13 chromosomal arms. In this repair loci, childhood T cell leukemia; relapse paper, we present the first documented case of a childhood tumor associated with a mutator phenotype. Introduction
Materials and methods
Acute lymphoblastic leukemia (ALL) constitutes the most frequent cancer encountered in children and accounts for T cell ALL patients approximately 20% of adult acute leukemia. Leukemogenesis is poorly understood genetically, although the clinical, pathoWe studied six children that were diagnosed with T-ALL by logical, and immunophenotypic features are well docuimmunophenotyping in the Division of Hematologymented.
1 Characterized by a predominance of lymphoblasts Oncology, Ste-Justine Hospital. Written informed consent was in bone marrow, ALL appears to arise from the clonal proliferobtained from the patients or the parents, and all studies ation of a single precursor cell that underwent genetic alterreceived approval from our institutional Bioethic Committee. ations leading to unregulated growth and arrested differenPatient ALL24 is a 13-year-old Caucasian girl who suffered tiation. Oncogenes and tumor suppressor genes are likely to bone pain, malaise and fatigue for 1 month prior to hospitalizbe involved in this multistep process.
2 Recently, another ation. Examination of her peripheral blood (PB) revealed a group of genes encoding components of the DNA replication white blood cell count (WBC) of 148 000/ml with 80 g/l hemand mismatch repair systems (hMSH2, hMLH1, hPMS1 and oglobin. Using the Boston Protocol (91-001) she achieved a hPMS2), has been shown to be directly involved in carcinoclinical and hematological remission (CR) at day 31. Six genesis.
3-7 Defects in these genes lead to an increase in replimonths post-diagnosis, she relapsed with 29 000 WBC in PB. cation errors, also called mutator phenotype. [8] [9] [10] Genomic She was re-induced but never achieved remission and died of instability at simple repeated sequences (microsatellites) raninfection 4 months after relapse. ALL14 achieved CR (using domly distributed throughout the genome has been used as a Boston Protocol 87-001) at day 21 but relapsed 4 years postmarker for the mutator phenotype in both sporadic and herdiagnosis. A second CR was obtained prior to an allogeneic editary forms of cancer. [11] [12] [13] bone marrow transplant and he is still free of disease a year T cell ALL representing approximately 15% of cases in chillater. ALL21, ALL23, ALL32 and ALL37 achieved CR on day dren, is associated with a poor prognosis as compared to the 31 and are free of disease after 34, 42, 21 and 50 weeks on predominant pre-B cell type. Both are heterogeneous diseases protocol (Boston 91-001), respectively.
normal DNA was isolated from either buccal epithelial cells Results or bone marrow in remission. Genomic DNA was isolated from bone marrow mononuclear cells, fractionated by centriDetection of allelic losses in T cell ALL patients fugation on a Ficoll-Paque (Pharmacia, Montreal, Canada) gradient, using a modified proteinase K/phenol protocol.
18
In order to identify the genetic steps involved in the development of childhood T cell ALL, we initiated a systematic search High molecular weight DNA was also extracted from mouth swabs.
19 Buccal epithelial cells collected on sterile swabs for specific genetic alterations with 56 microsatellites covering 13 chromosomal arms. Six patients were analyzed by comparwere immersed in 600 l of 50 mM NaOH, mixed by vortexing and incubated for 5 min at 95°C. The swab was careing the allelic pattern generated from genomic DNA isolated from tumoral cells with the pattern obtained from its normal fully removed and the DNA containing solution neutralized with 1/10th volume of 1 M Tris-HCl (pH 8.0). A 3 l DNA. Differences were detected in five of the six patients tested (Table 1 ). The absence of genetic alterations in ALL14 ( 2.5 ng/l) aliquot was added to a final 20 l PCR reaction mixture.
could be explained by the high number of normal contaminating cells. To eliminate the possibility of PCR artifacts and/or sample contamination, each result was reproduced once in independent PCR reactions and reloaded on separate gels.
Microsatellite analysis
The possibility of contamination with DNA from another individual was ruled out by the fact that microsatellite typings The following microsatellites (provided by Research Genetics, Huntsville, AL, USA) were used in this study: chromosome 3p
were consistent. The microsatellite markers used in this study allowed the detection of losses of heterozygosity (LOH) in (D3S659, D3S1038, D3S1217, D3S1263, D3S1266, D3S1286, D3S1304), 5q (D5S409, D5S433, D5S436, IRF1, chromosomes 6p, 12p and 9p. IFNA and D9S169 were both hemizygously deleted in 67% of the patients (four out of six) MCC), 6p (D6S89, D6S260, D6S276, TCTE1), 6q (D6S268, D6S246, D6S305, D6S314), 9p (D9S12, D9S159, D9S169, indicating the possible involvement of a tumor suppressor gene localized on chromosome 9p21, p16 ink4a (cdkn2/mts1) D9S1747, D9S1748, IFNA), 11p (D11S861, D11S905, D11S935), 11q (D11S29, D11S490, INT2), 12p (D12S62, being the most likely candidate gene. 22, 23 Since homozygous deletion seemed to be the usual inactivation pathway of D12S77, D12S87, D12S89, D12S94, D12S98, D12S269, D12S310, D12S320, D12S339, D12S356, D12S358), 13q p16, 14 we analyzed further the allelic status of the p16 region using the closest flanking markers, D9S1747 and D9S1748, (D13S153, D13S155, D13S170), 17p (D17S796, D17S806, P53), 17q (D17S579, D17S783, D17S806, THRA1, NF1), 18p known to detect the highest frequency of homozygous p16 deletion. 24 Three out of the four 9p21 deleted patients (ALL21, (D18S53), 18q (D18S51, D18S70). Each PCR reaction mixture contained 7.5 ng of genomic DNA, 0.2 M of each primer, ALL23 and ALL37) were heterozygous at D9S1748, while ALL32 showed LOH at the same locus (data not shown). This 50 M dNTPs, 1 Ci of ␣-32 P dCTP (NEN-Dupont, Boston, MA, USA; specific activity 3000 Ci/mmol), 10 mM Tris-HCl apparent retention of heterozygosity at one locus within a large deletion was suggestive of a homozygous deletion as (pH 8.3), 50 mm KCl, 1.5 mm MgCl 2 , and 0.4 U of Taq DNA polymerase (BRL, Burlington, Canada), in a final volume of discussed in Cairns et al. 24 This observation was supported by a multiplex PCR approach (described in Ref. 25), 25 using pri-20 l. After an initial denaturation at 94°C for 3 min, PCR amplifications were performed for 28 cycles of denaturation, mers for both D9S1748 and a control locus, that revealed a decrease in intensity in both D9S1748 alleles compared to the 94°C 30 s; annealing, 50-60°C 60 s, extension, 72°C 60 s; followed by a final extension step of 7 min at 72°C. PCR reaction control (data not shown). In patient ALL32, the remaining p16 allele may have inactivating mutations. products were analyzed on a 6% sequencing gel. the addition of 1 U Taq DNA polymerase (BRL), the reactions
Analysis of clonal evolution
were incubated for 7 min at 94°C, followed by 35 cycles of
denaturation (94°C, 60 s), annealing (62°C, 60 s) and elongation (72°C, 60 s). The PCR products were analyzed as P, age at first presentation; R, age at relapse; MSI, microsatellite instability.
described above.
ferent chemotherapy treatments. None of the patients who underwent similar treatments, including ALL14 who also relapsed, were found to be associated with microsatellite instability (Table 1) . This indicates that the allelic size alterations observed are probably not a consequence of therapeutics. Allelic losses were detected in most patients including the one with a mutator phenotype (Table 1) , indicating no apparent relationship between these two phenomena, except for p16 that was apparently intact in ALL24. In the light of these results, all patients were analyzed for their allelic status at six DNA mismatch repair loci: hMLH1, hMSH2, hMSH3, GTBP, hPMS1 and hPMS2 (data not shown). Only patient ALL24 showed genetic alterations at one or more of these loci (Table 3) , in which the hPMS2 locus was hemizygously deleted both at presentation and at relapse, suggesting the potential involvement of this gene in the observed genomic instability.
Analysis of clonality
Leukemic cells at diagnosis and relapse usually exhibit similar cytogenetic and phenotypic characteristics. 26 The distinct allelic patterns obtained at presentation and at relapse could be explained by the development of a second leukemia, a relapse-specific clonal evolution or mutation in the initial resistant malignant cells. In patient ALL24, the latter possibility ( Figure 2 ). This is based on the observation that clonal evolution of leukemic cell populations is characterized by uniform Detection of widespread microsatellite instabilities in rearrangements of immunoglobulin or TCR genes, as comone T cell ALL patient pared with the heterogeneous pattern of rearrangements observed in populations of normal T and B lymphocytes. In Patient ALL24 showed a great variability in microsatellite patboth systems, we observed a distinct band specific to the terns (Figure 1 ). We observed both contractions and expanmalignant clone present at diagnosis (Figure 2a ). DNA sions of the length of (CA)n in 27% (15/56) and 30% (17/56) sequencing of both PCR products generated from the amplifiof alleles tested at presentation and at relapse, respectively cation of the IgH locus provides strong evidence that they ( Table 2 ). The alterations were variable ranging from a 2 bp were derived from the same clone (Figure 2b) . Deletion of the change (type II mutation) with some markers, to larger size TCR locus in leukemic cells is well documented 27 and might changes in others (type I mutation) (Figure 1 ) and were similar explain the disappearance of the TCR-derived band at relapse to those described in other types of cancer. 8, 10, 12 At relapse, (Figure 2a ). The presence of identical LOH and an identical 6 months after diagnosis, patient ALL24 was refractory to difrearranged IgH locus suggests a homogenous clonal evolution. The intra-tumor heterogeneity could be explained by the persistence of the mutator phenotype after transformation, loss. In particular, the chromosome 9p21 was associated with deletions in 67% of T cell ALL patients tested. The gene, p16,
Shared unstable genomic loci are indicated in boldtype.
localized in this chromosomal region is likely to be the target
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